Documentation Centre

September 13, 2017
'Should we reconsider the role of age in treatment allocation for primary prevention of cardiovascular disease?' No, but we can improve risk communication metrics. Eur Heart J. 2017;38:1548-1552
Jackson R, Kerr A, Wells S

Description of this Publication

Consult publication on external website

By clicking on this link, you will leave the INTERNATIONAL CHAIR ON CARDIOMETABOLIC RISK website

Key Words
Age, Cardiovascular Disease, Prevention